Yiding Chen

17PUBLICATIONS
72CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birthPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 20, 2026
Recent Advances in Antibody-Drug Conjugates and Immunotherapy Combinations for Treatment of Triple-Negative Breast Cancer.

Huihui Chen, Wei Lu, Yunxiang Zhou

|Mar 06, 2026
Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment.

Yuxuan Zhu, Siwei Zheng, Yinkuan Shao

|Aug 02, 2024
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China.

Chunwei Xu, Zhanhong Chen, Yuanli Xia

|May 07, 2024
Leptomeningeal metastasis of breast cancer during neo-adjuvant chemotherapy in a 38-year-old woman: a case report.

Yao Jin, Jinglu Lu, Ting Zhang

|Jan 08, 2024
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.

Zefei Jiang, Quchang Ouyang, Tao Sun

|Dec 14, 2023
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial.

Yabing Zheng, Wen-Ming Cao, Xiying Shao

Pageof 3

Frequent Collaborators

3 joint publications

Jiaojiao Zhou

2 joint publications

Xiaojia Wang

2 joint publications

Jianyun Nie

2 joint publications

Shijie Wu